Medscape

Intravitreal Bevacizumab Injections for Retinopathy of Prematurity: 5 Years of Follow-up

Martínez-Castellanos and colleagues evaluated ocular function, neurodevelopment, and growth in infants treated with intravitreal bevacizumab injections for retinopathy of prematurity (ROP) during a ...
Nature

Sequential combined treatment with intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation

To study visual and anatomical outcomes of sequenced combined therapy using intravitreal bevacizumab followed by photodynamic therapy (PDT) in eyes with retinal angiomatous proliferation (RAP). Safety ...
JSTOR Daily

Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular ...

This is a preview. Log in through your library . Abstract Purpose Patients with neovascular age-related macular degeneration (nARMD) will not deteriorate on visual acuity and retinal thickness when ...
Managed Healthcare Executive

FDA issues third rejection of bevacizumab to treat wet AMD

The FDA issued a third complete response letter for ONS-5010/Lytenava, requesting confirmatory efficacy evidence for wet AMD treatment. Lytenava is an ophthalmic bevacizumab formulation, potentially ...
Healio

No differences found for bevacizumab in retinal vein occlusion across racial groups

NEW YORK — There were no significant differences in response to bevacizumab injections in patients across different races who had macular edema caused by retinal vein occlusion, according to a study. ...
Healio

Bevacizumab step therapy for wet AMD may be effective for majority of patients

Please provide your email address to receive an email when new articles are posted on . Patients treated with a step therapy protocol of bevacizumab injections for neovascular age-related macular ...
The American Journal of Managed Care

Considerations for Use of Bevacizumab-vikg in Wet AMD

Nicholas G. Anderson, MD, leads a discussion on how the first ophthalmic formulation of bevacizumab may impact the wet AMD treatment paradigm. Jim Kenney, RPh, MBA: We don’t always get extrapolation ...
ascopubs.org

The efficacy of pemetrexed and bevacizumab intrapleural injection for malignant pleural mesothelioma-mediated malignant pleural effusion.

Mesothelioma in the United States: A Surveillance, Epidemiology and End Results (SEER)-Medicare investigation of treatment patterns and survival. This is an ASCO Meeting Abstract from the 2015 ASCO ...
Nasdaq

Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with ...

SAN FRANCISCO and SUZHOU, China, Nov. 22, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
News Medical

Risk for endophthalmitis no higher with Avastin, finds study

Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug ...
Morningstar

BioDlink Accelerates Global Expansion with Bevacizumab Launch in Colombia and Pakistan

- BioDlink's bevacizumab injection secures marketing authorization in Colombia and Pakistan following its recent approval in Nigeria, marking key regulatory milestones in high-need emerging markets. - ...